Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Influenza virus aerosols in human exhaled breath: particle size, culturability, and effect of surgical masks.

Milton DK, Fabian MP, Cowling BJ, Grantham ML, McDevitt JJ.

PLoS Pathog. 2013 Mar;9(3):e1003205. doi: 10.1371/journal.ppat.1003205. Epub 2013 Mar 7.

2.

Viral kinetics and exhaled droplet size affect indoor transmission dynamics of influenza infection.

Chen SC, Chio CP, Jou LJ, Liao CM.

Indoor Air. 2009 Oct;19(5):401-13. doi: 10.1111/j.1600-0668.2009.00603.x. Epub 2009 Feb 28.

PMID:
19659895
3.

Influenza virus in human exhaled breath: an observational study.

Fabian P, McDevitt JJ, DeHaan WH, Fung RO, Cowling BJ, Chan KH, Leung GM, Milton DK.

PLoS One. 2008 Jul 16;3(7):e2691. doi: 10.1371/journal.pone.0002691.

4.

Exposure to influenza virus aerosols during routine patient care.

Bischoff WE, Swett K, Leng I, Peters TR.

J Infect Dis. 2013 Apr;207(7):1037-46. doi: 10.1093/infdis/jis773. Epub 2013 Jan 30.

PMID:
23372182
5.

Measurements of airborne influenza virus in aerosol particles from human coughs.

Lindsley WG, Blachere FM, Thewlis RE, Vishnu A, Davis KA, Cao G, Palmer JE, Clark KE, Fisher MA, Khakoo R, Beezhold DH.

PLoS One. 2010 Nov 30;5(11):e15100. doi: 10.1371/journal.pone.0015100.

6.

Detection of infectious influenza virus in cough aerosols generated in a simulated patient examination room.

Noti JD, Lindsley WG, Blachere FM, Cao G, Kashon ML, Thewlis RE, McMillen CM, King WP, Szalajda JV, Beezhold DH.

Clin Infect Dis. 2012 Jun;54(11):1569-77. doi: 10.1093/cid/cis237. Epub 2012 Mar 29.

7.

Exhaled aerosol transmission of pandemic and seasonal H1N1 influenza viruses in the ferret.

Koster F, Gouveia K, Zhou Y, Lowery K, Russell R, MacInnes H, Pollock Z, Layton RC, Cromwell J, Toleno D, Pyle J, Zubelewicz M, Harrod K, Sampath R, Hofstadler S, Gao P, Liu Y, Cheng YS.

PLoS One. 2012;7(4):e33118. doi: 10.1371/journal.pone.0033118. Epub 2012 Apr 3.

8.

Viable influenza A virus in airborne particles from human coughs.

Lindsley WG, Noti JD, Blachere FM, Thewlis RE, Martin SB, Othumpangat S, Noorbakhsh B, Goldsmith WT, Vishnu A, Palmer JE, Clark KE, Beezhold DH.

J Occup Environ Hyg. 2015;12(2):107-13. doi: 10.1080/15459624.2014.973113.

9.

Quantity and size distribution of cough-generated aerosol particles produced by influenza patients during and after illness.

Lindsley WG, Pearce TA, Hudnall JB, Davis KA, Davis SM, Fisher MA, Khakoo R, Palmer JE, Clark KE, Celik I, Coffey CC, Blachere FM, Beezhold DH.

J Occup Environ Hyg. 2012;9(7):443-9. doi: 10.1080/15459624.2012.684582.

10.

Validation and application of models to predict facemask influenza contamination in healthcare settings.

Fisher EM, Noti JD, Lindsley WG, Blachere FM, Shaffer RE.

Risk Anal. 2014 Aug;34(8):1423-34. doi: 10.1111/risa.12185. Epub 2014 Mar 4.

11.

Virus shedding and environmental deposition of novel A (H1N1) pandemic influenza virus: interim findings.

Killingley B, Greatorex J, Cauchemez S, Enstone JE, Curran M, Read RC, Lim WS, Hayward A, Nicholson KG, Nguyen-Van-Tam JS.

Health Technol Assess. 2010 Oct;14(46):237-354. doi: 10.3310/hta14460-04.

12.

Modes of transmission of influenza B virus in households.

Cowling BJ, Ip DK, Fang VJ, Suntarattiwong P, Olsen SJ, Levy J, Uyeki TM, Leung GM, Peiris JS, Chotpitayasunondh T, Nishiura H, Simmerman JM.

PLoS One. 2014 Sep 30;9(9):e108850. doi: 10.1371/journal.pone.0108850. eCollection 2014.

13.

Influenza aerosols in UK hospitals during the H1N1 (2009) pandemic--the risk of aerosol generation during medical procedures.

Thompson KA, Pappachan JV, Bennett AM, Mittal H, Macken S, Dove BK, Nguyen-Van-Tam JS, Copley VR, O'Brien S, Hoffman P, Parks S, Bentley A, Isalska B, Thomson G; EASE Study Consortium..

PLoS One. 2013;8(2):e56278. doi: 10.1371/journal.pone.0056278. Epub 2013 Feb 13.

14.

Effectiveness of surgical masks against influenza bioaerosols.

Makison Booth C, Clayton M, Crook B, Gawn JM.

J Hosp Infect. 2013 May;84(1):22-6. doi: 10.1016/j.jhin.2013.02.007. Epub 2013 Mar 14.

PMID:
23498357
15.

Development and Performance Evaluation of an Exhaled-Breath Bioaerosol Collector for Influenza Virus.

McDevitt JJ, Koutrakis P, Ferguson ST, Wolfson JM, Fabian MP, Martins M, Pantelic J, Milton DK.

Aerosol Sci Technol. 2013 Jan 1;47(4):444-451. Epub 2013 Jan 25.

16.

Absence of detectable influenza RNA transmitted via aerosol during various human respiratory activities--experiments from Singapore and Hong Kong.

Tang JW, Gao CX, Cowling BJ, Koh GC, Chu D, Heilbronn C, Lloyd B, Pantelic J, Nicolle AD, Klettner CA, Peiris JS, Sekhar C, Cheong DK, Tham KW, Koay ES, Tsui W, Kwong A, Chan K, Li Y.

PLoS One. 2014 Sep 10;9(9):e107338. doi: 10.1371/journal.pone.0107338. eCollection 2014.

17.

Respiratory virus RNA is detectable in airborne and droplet particles.

Gralton J, Tovey ER, McLaws ML, Rawlinson WD.

J Med Virol. 2013 Dec;85(12):2151-9. doi: 10.1002/jmv.23698. Epub 2013 Aug 19.

PMID:
23959825
18.

Viable influenza A virus in airborne particles expelled during coughs versus exhalations.

Lindsley WG, Blachere FM, Beezhold DH, Thewlis RE, Noorbakhsh B, Othumpangat S, Goldsmith WT, McMillen CM, Andrew ME, Burrell CN, Noti JD.

Influenza Other Respir Viruses. 2016 Sep;10(5):404-13. doi: 10.1111/irv.12390. Epub 2016 Apr 15.

19.

Environmental Conditions Affect Exhalation of H3N2 Seasonal and Variant Influenza Viruses and Respiratory Droplet Transmission in Ferrets.

Gustin KM, Belser JA, Veguilla V, Zeng H, Katz JM, Tumpey TM, Maines TR.

PLoS One. 2015 May 13;10(5):e0125874. doi: 10.1371/journal.pone.0125874. eCollection 2015.

20.

High infectivity and pathogenicity of influenza A virus via aerosol and droplet transmission.

Teunis PF, Brienen N, Kretzschmar ME.

Epidemics. 2010 Dec;2(4):215-22. doi: 10.1016/j.epidem.2010.10.001. Epub 2010 Oct 19.

Supplemental Content

Support Center